The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

Diabetic Macular Edema Market valuation is set to cross USD 4,642.9 million by 2034, at a CAGR of 1.2% through 2034.

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

While most gene therapy research has focused on rare disease, new results are out for a possible treatment for wet-AMD, the ...

A recent study conducted by researchers from Shanghai Jiao Tong University School of Medicine and Fudan University has ...

The new medication was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May.

Ailsa Slui, 80, says she would be blind by now if she hadn't sought medical help.

About The American Macular Degeneration Foundation The American Macular Degeneration Foundation ( macular.org) is a ...

There’s currently no cure or way to reverse macular degeneration. But you can slow down and prevent this eye disease from worsening and affecting your vision with treatments like eye health ...

Cystoid macular edema risk is lower for those using prostaglandin analogs than those using any other common class of glaucoma topical.

Number 5: The FDA has approved Pavblu (aflibercept-ayyh), the fifth biosimilar referencing Eylea (aflibercept).1 The new ...

Phase 3 SAGA trial has revealed that Gildeuretinol clinically, meaningfully and safely reduced geographic atrophy lesions ...